Effective August 2, 2022, mdxhealth has acquired the Oncotype DX Genomic Prostate Score (GPS) test from Exact Sciences. Additionally, Genomic Health Inc, part of Exact Sciences, will continue to perform the GPS test during the transition. Further communications explaining transition plans will be provided in the coming months. For more details, please review the press release.
Questions? Email: gps@mdxhealth.com

Treat your patient with exactly what they need

The Oncomap™ portfolio of tests leverages the underlying biology of cancer into curated therapy options that are optimal for your patient.

Gone are the days of undirected systemic treatment. Here are the days of precision oncology. Where optimal outcomes come with fewer obstacles, clinically actionable data serves as your compass, and therapy options that match your patient’s needs are ready to make an impact.

Oncomap Tests

Connect your patients to therapeutic and clinical trials options specific to their genomic alterations.

Order a Test

Tests are available through the physician portal. You must first request a specimen kit to submit a sample by calling +1 866-662-6897 before completing a requisition form on the portal. Once ordered, we then work with the pathology team or treating physician to obtain the sample using the specimen kit.